» Articles » PMID: 27680518

Filling the Midface: Injectables

Overview
Date 2016 Sep 30
PMID 27680518
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Volumizing the face has become commonplace on the facial aesthetic scene, with a rapid explosion of popularity in the field of nonsurgical rejuvenation. Three-dimensional enhancement of the midface with fillers provides the surgeon with a minimal downtime opportunity to treat early aging or reverse nonsurgical volume loss. With new products come advancements in techniques and the understanding of reversal of the effects of aging. While providing minimal downtime and risk, complications can occur and the physician must be able to recognize and treat these issues. It is crucial for the injector to understand and process these factors to ensure patient satisfaction and safety.

Citing Articles

Synthesis and Properties of Injectable Hydrogel for Tissue Filling.

Xie C, Liu G, Wang L, Yang Q, Liao F, Yang X Pharmaceutics. 2024; 16(3).

PMID: 38543325 PMC: 10975320. DOI: 10.3390/pharmaceutics16030430.


Rhinofiller: Fat Grafting (Surgical) Versus Hyaluronic Acid (Non-Surgical).

Gentile P Aesthetic Plast Surg. 2022; 47(2):702-713.

PMID: 36470985 DOI: 10.1007/s00266-022-03209-7.


Injection Guidelines for Treating Midface Volume Deficiency With Hyaluronic Acid Fillers: The ATP Approach (Anatomy, Techniques, Products).

Trevidic P, Kaufman-Janette J, Weinkle S, Wu R, Dhillon B, Antunes S Aesthet Surg J. 2022; 42(8):920-934.

PMID: 35039828 PMC: 9373948. DOI: 10.1093/asj/sjac007.